[1]Müller BM, Kistner U, Kindler S, et al. SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo[J]. Neuron, 1996, 17(2): 255-265.
[2]Fujita A, Kurachi Y. SAP family proteins[J]. Biochem Biophys Res Commun, 2000, 269(1): 1-6.
[3]Zheng CY, Petralia RS, Wang YX, et al. SAP102 is a highly mobile MAGUK in spines[J]. J Neurosci, 2010, 30(13): 4757-4766.
[4]Chen BS, Thomas EV, SanzClemente A, et al. NMDA receptor-dependent regulation of dendritic spine morphology by SAP102 splice variants[J]. J Neurosci, 2011, 31(1): 89-96.
[5]Wei Z, Behrman B, Wu WH, et al. Subunit-specific regulation of N-methyl-d-aspartate (NMDA) receptor trafficking by SAP102 protein splice variants[J]. J Biol Chem, 2015, 290(8): 5105-5116.
[6]Bustos FJ, Varela-Nallar L, Campos M, et al. PSD95 suppresses dendritic arbor development in mature hippocampal neurons by occluding the clustering of NR2B-NMDA receptors[J]. PLoS One, 2014, 9(4): e94037.
[7]Murata Y, Constantine-Paton M. Postsynaptic density scaffold SAP102 regulates cortical synapse development through EphB and PAK signaling pathway[J]. J Neurosci, 2013, 33(11): 5040-5052.
[8]Sans N, Petralia RS, Wang YX, et al. A developmental change in NMDA receptor-associated proteins at hippocampal synapses[J]. J Neurosci, 2000, 20(3): 1260-1271.
[9]Matsunaga Y, Negishi T, Hatakeyama A, et al. Impairment of synaptic development in the hippocampus of diabetic Goto-Kakizaki rats[J]. Int J Dev Neurosci, 2016, 53: 58-67.
[10]Proctor DT, Coulson EJ, Dodd PR. Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology[J]. J Alzheimers Dis, 2010, 21(3): 795-811.
[11]Farzana F, Zalm R, Chen N, et al. Neurobeachin regulates glutamate- and GABA-receptor targeting to synapses via distinct pathways[J]. Mol Neurobiol, 2016, 53(4):2112-2123.
[12]van Zundert B, Yoshii A, Constantine-Paton M. Receptor compartmentalization and trafficking at glutamate synapses: a developmental proposal[J]. Trends Neurosci, 2004, 27(7): 428-437.
[13]Chen BS, Gray JA, Sanz-Clemente A, et al. SAP102 mediates synaptic clearance of NMDA receptors[J]. Cell Rep, 2012, 2(5): 1120-1128.
[14]Sans N, Wang PY, Du Q, et al. mPins modulates PSD-95 and SAP102 trafficking and influences NMDA receptor surface expression[J]. Nat Cell Biol, 2005, 7(12): 1179-1190.
[15]Washbourne P, Liu XB, Jones EG, et al. Cycling of NMDA receptors during trafficking in neurons before synapse formation[J]. J Neurosci, 2004, 24(38): 8253-8264.
[16]Elias GM, Apostolides PF, Kriegstein AR, et al. Differential trafficking of AMPA and NMDA receptors by SAP102 and PSD-95 underlies synapse development[J]. Proc Natl Acad Sci, 2008, 105(52): 20953-20958.
[17]Lauks J, Klemmer P, Farzana F, et al. Synapse associated protein 102 (SAP102) binds the C-terminal part of the scaffolding protein neurobeachin[J]. PLoS One, 2012, 7(6): e39420.
[18]Davey F, Hill M, Falk J, et al. Synapse associated protein 102 is a novel binding partner to the cytoplasmic terminus of neurone-glial related cell adhesion molecule[J]. J Neurochem, 2005, 94(5): 1243-1253.
[19]Thurner P, Gsandtner I, Kudlacek O, et al. A two-state model for the diffusion of the a2a adenosine receptor in hippocampal neurons agonist-induced switch to slow mobility is modified by synapse-associated protein 102 (sap102)[J]. J Biol Chem, 2014, 289(13): 9263-9274.
[20]Bécamel C, Gavarini S, Chanrion B, et al. The serotonin 5-HT2A and 5-HT2C receptors interact with specific sets of PDZ proteins[J]. J Biol Chem, 2004, 279(19): 20257-20266.
[21]Zanni G, Van Esch H, Bensalem A, et al. A novel mutation in the DLG3 gene encoding the synapse-associated protein 102 (SAP102) causes non-syndromic mental retardation[J]. Neurogenetics, 2010, 11(2): 251-255.
[22]Kumar R, Ha T, Pham D, et al. A non-coding variant in the 5’UTR of DLG3 attenuates protein translation to cause non-syndromic intellectual disability[J]. Eur J Hum Genet, 2016, 24(11):1612-1616.
[23]Crocker-Buque A, Currie SP, Luz LL, et al. Altered thalamocortical development in the SAP102 knockout model of intellectual disability[J]. Hum Mol Genet, 2016, 25(18):4052-4061.
[24]Kristiansen LV, Beneyto M, Haroutunian V, et al. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia[J]. Mol Psychiatry, 2006, 11(8): 737-747.
[25]Clinton SM, Haroutunian V, Meador-Woodruff JH. Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia[J]. J Neurochem, 2006, 98(4): 1114-1125.
[26]Meador-Woodruff JH, Clinton SM, Beneyto M, et al. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia[J]. Ann NY Acad Sci, 2003, 1003(1): 75-93.
[27]Zhang Y, Li P, Feng J, et al. Dysfunction of NMDA receptors in Alzheimer’s disease[J]. Neurol Sci, 2016: 37(7):1039-1047.
[28]Fan J, Cowan CM, Zhang LYJ, et al. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease[J]. J Neurosci, 2009, 29(35): 10928-10938.
[29]Ricobaraza A, Cuadrado-Tejedor M, Marco S, et al. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease[J]. Hippocampus, 2012, 22(5): 1040-1050.
|